Liarozole: Difference between revisions

Content deleted Content added
No edit summary
 
(7 intermediate revisions by 7 users not shown)
Line 3:
| ImageSize = 200px
| ImageAlt =
| IUPACNamePIN = 6-[(3-Chlorophenyl)(1''H''-imidazol-1-ylmethylyl)methyl]-1''H''-1,3-benzimidazole
| OtherNames =
|Section1={{Chembox Identifiers
| IUPHAR_ligand = 5210
| CASNo = 115575-11-6
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = K0Q29TGV9Y
| CASNo_Ref = {{cascite|correct|CAS}}
| PubChem = 60652
| SMILES =C1=CC(=CC(=C1)Cl)C(C2=CC3=C(C=C2)N=CN3)N4C=CN=C4
Line 28 ⟶ 31:
}}
 
'''Liarozole''' is a [[retinoic acid]] metabolism-blocking drug and [[aromatase inhibitor]].<ref>{{cite journal|pmid=24102348|year=2013|last1=Vahlquist|first1=A|last2=Blockhuys|first2=S|last3=Steijlen|first3=P|last4=Van Rossem|first4=K|last5=Didona|first5=B|last6=Blanco|first6=D|last7=Traupe|first7=H|title=Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: Results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial|doi=10.1111/bjd.12626|journal=The British journalJournal of dermatologyDermatology|pages=173–81|volume=170|issue=1|pmc=4232915}}</ref> Liarozole is an [[isomer]] of [[alprazolam]], but the two compounds are completely unrelated.
 
==Synthesis==
[[File:Liarozole synthesis.png|thumb|left|600px|Liarozole synthesis from Lednicer book 6 (Drugs of the Future citation).]]{{Clear}}
 
==References==
{{Reflist|2}}
 
{{NuclearRetinoid receptor modulators}}
 
{{Nuclear receptor modulators}}
 
[[Category:Aromatase inhibitors]]
[[Category:Benzimidazoles]]
[[Category:Chloroarenes3-Chlorophenyl compounds]]
[[Category:CYP17A1 inhibitors]]
[[Category:Imidazoles]]